The Effect of Prophylactic Adnexectomy on the Quality of Life and Psychosocial Functioning of Women with the BRCA1/BRCA2 Mutations

被引:6
|
作者
Stanisz, Marta [1 ]
Panczyk, Mariusz [2 ]
Kurzawa, Rafal [1 ,3 ]
Grochans, Elzbieta [4 ]
机构
[1] Pomeranian Med Univ, Dept Gynecol & Reprod Hlth, PL-71210 Szczecin, Poland
[2] Med Univ Warsaw, Dept Educ & Res Hlth Sci, PL-02091 Warsaw, Poland
[3] Ctr Gynecol & Treatmemt Infertil Vitrol, Al Wojska Polskiego 103, PL-70483 Szczecin, Poland
[4] Pomeranian Med Univ, Dept Nursing, Ul Zolnierska 48, PL-71210 Szczecin, Poland
关键词
BRCA1; BRCA2; risk-reducing salpingo-oophorectomy; quality of life; psychosocial functioning; ovarian cancer; REDUCING SALPINGO-OOPHORECTOMY; OVARIAN-CANCER; BREAST-CANCER; HEREDITARY BREAST; SEXUAL-ACTIVITY; INCREASED RISK; BRCA MUTATION; CARRIERS; IMPACT; THERAPY;
D O I
10.3390/ijerph16244995
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The main purpose of this study was to analyze the effect of risk-reducing salpingo-oophorectomy (RRSO) on the quality of life (QoL) and psychosocial functioning of patients with the BRCA1/BRCA2 mutations. This survey-based study was conducted using the Blatt-Kupperman Index, the Women's Health Questionnaire, the Perceived Stress Scale, the State-Trait Anxiety Inventory, the Beck Depression Inventory-II, and the authors' questionnaire. All calculations were done using Statistica 13.3. The QoL after RRSO was statistically significantly lower in most domains compared with the state before surgery. The greatest decline in the QoL was observed in the vasomotor symptoms domain (d = 0.953) and the smallest in the memory/concentration domain (d = 0.167). We observed a statistically significant decrease in the level of anxiety as a state (d = 0.381), as well as a statistically significant increase in the severity of climacteric symptoms (d = 0.315) and depressive symptoms (d = 0.125). Prophylactic surgeries of the reproductive organs have a negative effect on the QoL and psychosocial functioning of women with the BRCA1/2 mutations, as they increase the severity of depressive and climacteric symptoms. At the same time, these surgeries reduce anxiety as a state, which may be associated with the elimination of cancerophobia.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Can personality traits affect the quality of life of women with the BRCA1/BRCA2 mutations before and after prophylactic adnexectomy?
    Stanisz, M.
    Schneider-Matyka, D.
    Panczyk, M.
    Branecka-Wozniak, D.
    Kurzawa, R.
    Knyszynska, A.
    Grochans, E.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (23) : 12342 - 12349
  • [2] Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations
    Kearton, Stephanie
    Wills, Karen
    Bunting, Michael
    Blomfield, Penny
    James, Paul A.
    Burke, Jo
    FAMILIAL CANCER, 2018, 17 (03) : 333 - 344
  • [3] The quality of life associated with prophylactic treatments for women with BRCA1/2 mutations
    Grann, VR
    Jacobson, JS
    Sundararajan, V
    Albert, SM
    Troxel, AB
    Neugut, AI
    CANCER JOURNAL, 1999, 5 (05): : 283 - 292
  • [4] Molecular Trajectory of BRCA1 and BRCA2 Mutations
    Hatano, Yuichiro
    Tamada, Maho
    Matsuo, Mikiko
    Hara, Akira
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [5] BRCA1 and BRCA2 mutations and female fertility
    Smith, Ken R.
    Hanson, Heidi A.
    Hollingshaus, Michael S.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2013, 25 (03) : 207 - 213
  • [6] BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ
    Liu, Yan
    Ide, Yoshimi
    Inuzuka, Mayuko
    Tazawa, Sakiko
    Kanada, Yoko
    Matsunaga, Yuki
    Kuwayama, Takashi
    Sawada, Terumasa
    Akashi-Tanaka, Sadako
    Nakamura, Seigo
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (03):
  • [7] Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations
    Yao, Lu
    Sun, Jie
    Zhang, Juan
    He, Yingjian
    Ouyang, Tao
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Fan, Tie
    Lin, Benyao
    Xie, Yuntao
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (03) : 441 - 445
  • [8] Risk of cardiovascular disease in women with BRCA1 and BRCA2 mutations
    Powell, C. Bethan
    Alabaster, Amy
    Armstrong, Mary Anne
    Stoller, Nicole
    Raine-Bennett, Tina
    GYNECOLOGIC ONCOLOGY, 2018, 151 (03) : 489 - 493
  • [9] BRCA1 and BRCA2 mutations and the risk for colorectal cancer
    Sopik, V.
    Phelan, C.
    Cybulski, C.
    Narod, S. A.
    CLINICAL GENETICS, 2015, 87 (05) : 411 - 418
  • [10] Bone loss in women with BRCA1 and BRCA2 mutations
    Powell, C. Bethan
    Alabaster, Amy
    Stoller, Nicole
    Armstrong, Mary Anne
    Salyer, Chelsea
    Hamilton, Isabella
    Raine-Bennett, Tina
    GYNECOLOGIC ONCOLOGY, 2018, 148 (03) : 535 - 539